DKSH aims to be or remain among the best in the world in all dimensions of business excellence. Year after year, we are awarded for our attractiveness as an employer and for achievements in our areas of work.
By successfully completing the acquisition of life sciences distributor Bosung in Korea and medical devices distributor MedWorkz in Singapore, DKSH continues to drive market consolidation and expands its leading positions in Asia Pacific.
All proposals of the Board of Directors approved Marco Gadola confirmed as Chairman and all Board members re-elected Shareholders approve dividend rise to CHF 1.95 per share (+2.6%), representing a 2.7% yield¹
DKSH today announced two acquisitions in Asia Pacific. In Business Unit Technology, DKSH signed an agreement to acquire Bosung, a Korean life sciences distributor, and in Business Unit Healthcare, DKSH acquired medical device distributor MedWorkz in Singapore.